Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen and GlaxoSmithKline Enter New Pharmacogenomics Collaboration

NEW YORK, Oct. 12 (GenomeWeb News) - Perlegen Sciences said today that it will commence a high-density whole-genome scanning project with GlaxoSmithKline for the purposes of determining genetic variants associated with a specific GSK trait of interest, the second such collaboration between the companies.

 

GSK and Perlegen inked a similar agreement in September 2002. That project differed from the new collaboration in the specific trait of interest, Paul Cusenza, vice president of alliance management at Perlegen said.

 

Financial terms of the deal were not disclosed.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.